Stephen Gordon's Insider Trades & SAST Disclosures
Stephen Gordon's most recent trade in Zillow Group Inc - Ordinary Shares - Class A was a trade of 10,000 Class C Capital Stock done at an average price of $21.5 . Disclosure was reported to the exchange on May 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stephen Gordon.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.46 per share. | 13 May 2025 | 10,000 | 38,290 (0%) | 0% | 21.5 | 214,600 | Class C Capital Stock |
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Sale of securities on an exchange or to another person at price $ 70.69 per share. | 13 May 2025 | 10,000 | 28,290 (0%) | 0% | 70.7 | 706,883 | Class C Capital Stock |
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 10,000 | 6,835 | - | - | Stock Option (right to buy) | |
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 11,586 | 11,586 | - | - | Stock Option (right to buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.46 per share. | 03 Jun 2024 | 2,060 | 23,359 (0%) | 0% | 38.5 | 79,228 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 2,060 | 15,417 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 135.93 per share. | 03 Jun 2024 | 2,060 | 21,299 (0%) | 0% | 135.9 | 280,016 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 141.06 per share. | 29 May 2024 | 9,345 | 29,954 (0%) | 0% | 141.1 | 1,318,206 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 141.80 per share. | 29 May 2024 | 8,655 | 21,299 (0%) | 0% | 141.8 | 1,227,279 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 5,000 | 23,167 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 5,000 | 17,477 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 5,000 | 15,022 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.10 per share. | 29 May 2024 | 5,000 | 39,299 (0%) | 0% | 66.1 | 330,500 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.28 per share. | 29 May 2024 | 5,000 | 33,299 (0%) | 0% | 13.3 | 66,400 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.46 per share. | 29 May 2024 | 5,000 | 28,299 (0%) | 0% | 38.5 | 192,300 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 141.27 per share. | 29 May 2024 | 2,000 | 21,299 (0%) | 0% | 141.3 | 282,540 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 2,000 | 84 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.14 per share. | 29 May 2024 | 2,000 | 23,299 (0%) | 0% | 16.1 | 32,280 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.14 per share. | 29 May 2024 | 1,000 | 34,299 (0%) | 0% | 83.1 | 83,140 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 1,000 | 17,690 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.46 per share. | 06 May 2024 | 15,000 | 38,299 (0%) | 0% | 38.5 | 576,900 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 15,000 | 22,477 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 128.00 per share. | 06 May 2024 | 15,000 | 23,299 (0%) | 0% | 128 | 1,920,000 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.46 per share. | 01 Apr 2024 | 15,000 | 38,299 (0%) | 0% | 38.5 | 576,900 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 15,000 | 37,477 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 74.01 per share. | 01 Apr 2024 | 15,000 | 23,299 (0%) | 0% | 74.0 | 1,110,150 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.63 per share. | 08 Mar 2024 | 1,903 | 23,299 (0%) | 0% | 87.6 | 166,760 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 15,000 | 52,477 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.46 per share. | 04 Mar 2024 | 15,000 | 40,202 (0%) | 0% | 38.5 | 576,900 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 82.80 per share. | 04 Mar 2024 | 15,000 | 25,202 (0%) | 0% | 82.8 | 1,242,000 | Common Stock |
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 16,956 | 16,956 | - | - | Stock Option (right to buy) | |
| Transmedics Group Inc | Gordon Stephen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 18,690 | 18,690 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 12,127 | 25,202 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.45 per share. | 01 Feb 2024 | 15,000 | 13,075 (0%) | 0% | 85.5 | 1,281,750 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 8,833 | 28,167 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Gordon Stephen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.28 per share. | 01 Feb 2024 | 8,833 | 21,908 (0%) | 0% | 13.3 | 117,302 | Common Stock |
| Transmedics Group Inc | Gordon Stephen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,644 | 2,084 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.14 per share. | 01 Feb 2024 | 3,644 | 25,552 (0%) | 0% | 16.1 | 58,814 | Common Stock |
| Transmedics Group Inc | Gordon Stephen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 2,523 | 67,477 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Gordon Stephen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.46 per share. | 01 Feb 2024 | 2,523 | 28,075 (0%) | 0% | 38.5 | 97,035 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 15,000 | 37,000 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.28 per share. | 02 Jan 2024 | 15,000 | 28,075 (0%) | 0% | 13.3 | 199,200 | Common Stock |
| Transmedics Group Inc | Gordon Stephen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 77.07 per share. | 02 Jan 2024 | 15,000 | 13,075 (0%) | 0% | 77.1 | 1,156,050 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 5,000 | 10,728 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 79.05 per share. | 01 May 2023 | 5,000 | 18,789 (0%) | 0% | 79.1 | 395,250 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.14 per share. | 01 May 2023 | 5,000 | 23,789 (0%) | 0% | 16.1 | 80,700 | Common Stock |
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 10,353 | 10,353 | - | - | Stock Option (right to buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 79.51 per share. | 01 Mar 2023 | 5,000 | 18,789 (0%) | 0% | 79.5 | 397,550 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 5,000 | 15,728 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.14 per share. | 01 Mar 2023 | 5,000 | 23,789 (0%) | 0% | 16.1 | 80,700 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 20,022 | 20,022 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 13,075 | 18,789 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 5,000 | 20,728 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 62.64 per share. | 01 Feb 2023 | 5,000 | 5,714 (0%) | 0% | 62.6 | 313,200 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.14 per share. | 01 Feb 2023 | 5,000 | 10,714 (0%) | 0% | 16.1 | 80,700 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.12 per share. | 17 Jan 2023 | 5,000 | 5,714 (0%) | 0% | 60.1 | 300,600 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.14 per share. | 17 Jan 2023 | 5,000 | 10,714 (0%) | 0% | 16.1 | 80,700 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 5,000 | 25,728 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 10,000 | 30,728 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.14 per share. | 01 Dec 2022 | 10,000 | 15,714 (0%) | 0% | 16.1 | 161,400 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 61.30 per share. | 01 Dec 2022 | 9,969 | 5,745 (0%) | 0% | 61.3 | 611,100 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 62.16 per share. | 01 Dec 2022 | 31 | 5,714 (0%) | 0% | 62.2 | 1,927 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 56.72 per share. | 07 Nov 2022 | 10,000 | 5,714 (0%) | 0% | 56.7 | 567,200 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.14 per share. | 07 Nov 2022 | 9,272 | 15,714 (0%) | 0% | 16.1 | 149,650 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 9,272 | 40,728 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.21 per share. | 07 Nov 2022 | 728 | 6,442 (0%) | 0% | 2.2 | 1,609 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 728 | 0 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 41.74 per share. | 03 Oct 2022 | 10,000 | 5,714 (0%) | 0% | 41.7 | 417,400 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 10,000 | 728 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.21 per share. | 03 Oct 2022 | 10,000 | 15,714 (0%) | 0% | 2.2 | 22,100 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 10,000 | 10,728 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.21 per share. | 01 Sep 2022 | 10,000 | 15,714 (0%) | 0% | 2.2 | 22,100 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.93 per share. | 01 Sep 2022 | 10,000 | 5,714 (0%) | 0% | 50.9 | 509,300 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 10,000 | 20,728 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 48.09 per share. | 08 Aug 2022 | 10,000 | 5,714 (0%) | 0% | 48.1 | 480,900 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.21 per share. | 08 Aug 2022 | 10,000 | 15,714 (0%) | 0% | 2.2 | 22,100 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2022 | 10,000 | 30,728 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 05 Jul 2022 | 10,000 | 5,714 (0%) | 0% | 35 | 350,000 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.21 per share. | 05 Jul 2022 | 10,000 | 15,714 (0%) | 0% | 2.2 | 22,100 | Common Stock |
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,247 | 8,247 | - | - | Stock Option (right to buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 52,000 | 52,000 | - | - | Stock Option (Right to Buy) | |
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.94 per share. | 12 Jan 2022 | 6,290 | 28,290 (0%) | 0% | 39.9 | 251,225 | Class C Capital Stock |
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 6,290 | 0 | - | - | Stock Option (right to buy) | |
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 3,145 | 0 | - | - | Stock Option (right to buy) | |
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.62 per share. | 12 Jan 2022 | 3,145 | 16,145 (0%) | 0% | 34.6 | 108,876 | Class A Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 07 Sep 2021 | 10,000 | 5,714 (0%) | 0% | 35 | 350,000 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 07 Sep 2021 | 10,000 | 15,714 (0%) | 0% | 0.7 | 6,700 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 15 Jul 2021 | 10,000 | 5,714 (0%) | 0% | 35 | 350,000 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 15 Jul 2021 | 10,000 | 15,714 (0%) | 0% | 0.7 | 6,700 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 17 Jun 2021 | 10,000 | 5,714 (0%) | 0% | 30 | 300,000 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2021 | 10,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.66 per share. | 17 Jun 2021 | 10,000 | 10,000 (0%) | 0% | 0.7 | 6,650 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 5,714 | 29,999 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 01 Jun 2021 | 5,714 | 5,714 (0%) | 0% | 0.7 | 3,828 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 15 Mar 2021 | 10,000 | 10,000 (0%) | 0% | 0.7 | 6,700 | Common Stock |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 10,000 | 35,713 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.81 per share. | 15 Mar 2021 | 10,000 | 0 (0%) | 0% | 39.8 | 398,100 | Common Stock |
| Zillow Group Inc - Ordinar... | Gordon Sheridan Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 3,106 | 3,106 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Stephen Gordon | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges